Cannara Biotech, Inc. · TSX:LOVE
Cannara Biotech — Q1 2026 Earnings Presentation
22 slides from Cannara Biotech's earnings presentation, January 2026
Slide 1: Premium-Quality Cannabis at Scale
TSXV: LOVE | OTCQX: LOVFF | FRA: 8CB0 PREMIUM-QUALITY CANNABIS AT SCALE INVESTOR DECK Q1 FISCAL YEAR 2026 (AS OF NOVEMBER 30, 2025)
Slide 2: General Disclosures
General Disclosures Disclaimer This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the Company’s most recent Annual Information Form, as well as in the Company’s most recent consolidated financial statements, together wit
Slide 3: Forward-Looking Statements
General Disclosures Forward-Looking Statements This presentation may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this presentation and the Company does not inte
Slide 4: An Emerging Leader In Canada
An Emerging Leader In Canada Vertically-integrated licensed producer of premium-grade cannabis products Overview #1 LP by Sales1 Current 50,000 kg annualized Financials production ~$150M* net revenue run- Assets rate at an avg selling price of $3/g #1 Mass Premium Flower Brand Strategy #7 LP by Sale
Slide 5: Profitability Sets Us Apart
Profitability Sets Us Apart % Change Q1 2025 % Change Q1 2026 Q4 2025 QoQ Comparable Period YoY $42.8M $40.1M 7% $35.9M 19% $30.1M $28.3M 6% $25.0M 20% $13.5M $11.8M 14% $9.8M 38% Overview Financials 45% 42% 7% 39% 15% Assets $8.8M $7.4M 19% $6.0M 47% Strategy Performance 29% 26% 12% 24% 21% Cap Tab
Slide 6: Well Capitalized Balance Sheet
Well Capitalized Balance Sheet Selected Financial Highlights As at November 30, 2025 As at August 31, 2025 % Change Cash $16.5M $14.4 M 14.6% Accounts receivable $15.2M $14.1 M 7.8% Biological assets $5.9M $6.8 M (13.2%) Inventory $46.1M $44.5 M 3.6% Overview Financials Working capital1 $53.5M $48.0
Slide 7: Scaling Sales
Scaling Sales Cannabis Revenue Growth Trajectory as Valleyfield Production Scales Up Cannabis NET Revenue in $ Millions Gross Profit Before Fair Value Adjustment % Gross Margin $30.1 100% $28.3 Overview $27.3 90% $26.6 Financials $24.0 80% Assets $22.1 70% Strategy Performance $18.5 $18.8 $18.3 60%
Slide 8: Two Quebec Based Mega Facilities: Valleyfield
Two Quebec Based Mega Facilities Valleyfield: 1M sq. ft., 24 independent grow rooms, each 25,000 sq. ft. Overview Financials Assets Strategy Performance Cap Table Leadership Each activated zone has been designed to replicate indoor growing conditions eliminating variability and maximizing Summary Va
Slide 9: Two Quebec Based Mega Facilities: Farnham
Two Quebec Based Mega Facilities Farnham: 605,000 sq. ft., 170, 000 sq. ft. of cannabis operations Overview Financials Assets Strategy Performance Cap Table Leadership Summary Farnham Facility • 605,000 sq. ft. facility provides 190,000 sq. ft. of cannabis operations. • R&D Facility (Pheno-hunting,
Slide 10: Disciplined Growth & Expansion
Disciplined Growth & Expansion Cannara’s Estimated Fiscal Year End Production Capacity in kg 120,000 100000 100,000 Annualized Production (kg) 88,000 Overview 80,000 75,000 Financials Assets 65,000 Strategy 60,000 Performance 50,000 50,000 Cap Table Leadership 40,000 30,500 33,500 Total owned potent
Slide 11: Canadian Recreational Cannabis Market
Canadian Recreational Cannabis Market 2ND Largest Cannabis Market in the world Legal Cannabis Market expected to Monthly Retail Sales of Legal reach Cannabis Stores in Canada from ~$9.81 billion CDN (US$6.58 B) by 20291 October 2018 to December 20252 7 Retail sales in million CDN dollars Overview 6
Slide 12: Why Quebec
Why Quebec Average Electricity Rates By Province In Cents Per Kw Hour Quebec has the lowest electricity rates in Canada QC MB BC ON SK NS AB 5.9¢/kWh 6.0¢/kWh 7.4¢/kWh 10.3¢/kWh 11.1¢/kWh 11.6¢/kWh 14.1¢/kWh Overview Financials Assets Quebec has the highest barriers Strategy 578 510 282 151 of entry
Slide 13: Competitive Advantage
Competitive Advantage Price Community Innovation & Scalable Quality Competitiveness Customer Loyalty Engagement Rare Genetics Premium, craft-style Value-based pricing Consistent repeatable Direct engagement Continuous innovation quality delivered at enabled by Quebec’s experiences with a with consum
Slide 14: National Estimated Retail Sales Growth
National Estimated Retail Sales Growth National Q1 2026 Q4 2025 Licensed Producer $ QoQ Δ % QoQ Δ Sales Rank Total Retail Sales Total Retail Sales 1 Organigram $161.6M $174.8M -$13.2M -8% 2 Tilray $132.3M $138.0M -$5.7M -4% 3 Auxly Cannabis $87.9M $91.1M -$3.2M -3% Overview 4 Cronos $71.3M $70.6M $0
Slide 15: Increasing Our Market Share
Increasing Our Market Share Estimated Retail Market Growth1 Market December 2025 Q1 2026 FY 2025 FY 2024 National 4.4% 4.1% 3.8% 2.9% QC 14.7% 13.5% 12.7% 8.3% ON 3.4% 3.1% 2.8% 2.7% Overview AB 2.5% 2.5% 2.5% 1.9% Financials BC 2.0% 1.8% 1.6% 1.1% Assets Strategy SK 1.2% 0.9% 1.0% 1.1% Performance
Slide 16: Quebec Vape Launch
Quebec Vape Launch SQDC launched vape sales on November 26th, with Cannara earning 5/25 in-store listings Top 10 Estimated QC Vape Retail Sales as of December 2025 Licensed Producer Total Sales $ Nov – Dec 2025 % Vape Market Share Cannara $2.2M 29.7% Overview Organigram $1.1M 14.9% Financials Bleuh
Slide 17: Cannabis CPG Portfolio Leadership
Cannabis CPG Portfolio Leadership Overview Financials Canada’s #1 Infused pre-roll Canada’s #1 Hash rosin brand Canada’s #1 live rosin vape Assets Strategy Performance Cap Table Leadership Summary Canada’s #1 CBD flower Canada’s #1 Mass premium Canada’s #1 Premium live resin vape flower brand Q1 FY2
Slide 18: Capital Structure
Capital Structure As at January 23, 2026 As at October 3, 2025 As at August 31, 2025 As at August 31, 2024 94.9M 91.4M 90.0M Overview Average Estimated Market Capitalization Last 30 Days Financials $173M Assets Strategy Performance Cap Table Average Closing Share Price Last 30 Days $1.80 >50% Leader
Slide 19: Executive Leadership Team
Executive Leadership Team Zohar is an entrepreneur who has Nicholas Sosiak, CPA, is the Avi has been in the information launched several successful businesses. dynamic and hands-on CFO technology industry for over 20 He has founded, advised and invested of Cannara Biotech, years. He specializes in i
Slide 20: Executive Leadership Team
Executive Leadership Team ZOHAR KRIVOROT DONALD OLDS CHAIRMAN & CEO LEAD DIRECTOR & CHAIRMAN OF THE AUDIT Zohar is a seasoned entrepreneur who has built & GOVERNANCE COMMITTEE and grown multiple successful businesses. He has Donald Olds is an experienced life played pivotal roles as a founder, advis
Slide 21: Strategy Backed by Results
Strategy Backed by Results Premium quality at scale, delivered at disruptive prices, enabled by disciplined execution Overview Premium quality at scale Vertical integration Record Q1 2026 performance Financials cultivation → extraction → packaging and profitability Assets Strategy Disruptive pricing
Slide 22: Thank You
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 THANK YOU Overview Financials www.cannara.ca Assets Strategy investors.cannara.ca Performance Cap Table www.instagram.com/cannarabiotech Leadership Summary www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie blv